AU2001266573A1 - Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof - Google Patents

Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof

Info

Publication number: AU2001266573A1
Authority: AU; Australia
Prior art keywords: proliferative; compositions; methods; block copolymers; inflammatory diseases
Prior art date: 2000-05-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001266573A

Inventor

Valery Alakhov

Nadia Guerin

Alexander V Kabanov

Pierre Lemieux

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Supratek Pharma Inc

Original Assignee

Supratek Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-12

Filing date

2001-05-10

Publication date

2001-11-26

2001-05-10 Application filed by Supratek Pharma Inc filed Critical Supratek Pharma Inc

2001-11-26 Publication of AU2001266573A1 publication Critical patent/AU2001266573A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)

AU2001266573A 2000-05-12 2001-05-10 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof Abandoned AU2001266573A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20354900P	2000-05-12	2000-05-12
US60203549		2000-05-12
PCT/US2001/015265 WO2001087234A2 (en)	2000-05-12	2001-05-10	Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers

Publications (1)

Publication Number	Publication Date
AU2001266573A1 true AU2001266573A1 (en)	2001-11-26

Family

ID=22754435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001266573A Abandoned AU2001266573A1 (en)	2000-05-12	2001-05-10	Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof

Country Status (6)

Country	Link
US (1)	US6656459B2 (en)
EP (1)	EP1280537A2 (en)
JP (1)	JP2003533454A (en)
AU (1)	AU2001266573A1 (en)
CA (1)	CA2406013A1 (en)
WO (1)	WO2001087234A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1278551A2 (en)	2000-04-21	2003-01-29	Vical Incorporated	Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
US7256180B2 (en) *	2000-04-28	2007-08-14	Supratek Pharma Inc.	Compositions and methods for inducing activation of dendritic cells
US20040092102A1 (en) *	2002-11-12	2004-05-13	Sachem, Inc.	Chemical mechanical polishing composition and method
US20070237740A1 (en) *	2004-09-27	2007-10-11	Vical, Inc.	Formulations and Methods for Treatment of Inflammatory Diseases
CA2648007A1 (en) *	2006-04-24	2007-11-01	Bruce Medical Ab	Polymer-based anti-cancer agents
US9675696B2 (en) *	2006-11-14	2017-06-13	Warsaw Orthopedic, Inc.	Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US9511016B2 (en) *	2007-06-12	2016-12-06	Epicentrx, Inc.	Topical composition for treating pain
US8784872B2 (en)	2007-11-19	2014-07-22	Comgenrx, Inc.	Formulation for decreasing tobacco, alcohol, drug or food consumption
WO2009100011A2 (en) *	2008-02-01	2009-08-13	University Of Florida Research Foundation, Inc.	Targeted cellular selectivity of surface active molecules
US8716204B2 (en)	2010-07-27	2014-05-06	Zimmer, Inc.	Synthetic synovial fluid compositions and methods for making the same
US20140066523A1 (en) *	2011-05-03	2014-03-06	Abyrx, Inc.	Drug Delivery Compositions And Methods Of Use
CN117958209B (en) *	2024-01-15	2025-10-14	广东省人民医院	A sepsis animal model and its construction method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5166219A (en) *	1989-11-02	1992-11-24	Lidak Pharmaceuticals	Systemic anti-inflammatory treatment
US5840319A (en) *	1992-10-08	1998-11-24	Alakhov; Valery Yu	Biological agent compositions
US5824322A (en) *	1995-08-21	1998-10-20	Cytrx Corporation	Compositions and methods for growth promotion
US5834472A (en) *	1996-05-24	1998-11-10	Schering Corporation	Antifungal composition with enhanced bioavailability
US6159978A (en) *	1997-05-28	2000-12-12	Aventis Pharmaceuticals Product, Inc.	Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
WO2000028994A1 (en) *	1998-11-18	2000-05-25	Supratek Pharma Inc.	Copolymer compositions for treating viral infections

2001
- 2001-05-10 JP JP2001583703A patent/JP2003533454A/en not_active Withdrawn
- 2001-05-10 US US09/852,533 patent/US6656459B2/en not_active Expired - Fee Related
- 2001-05-10 EP EP01944132A patent/EP1280537A2/en not_active Withdrawn
- 2001-05-10 AU AU2001266573A patent/AU2001266573A1/en not_active Abandoned
- 2001-05-10 WO PCT/US2001/015265 patent/WO2001087234A2/en not_active Ceased
- 2001-05-10 CA CA002406013A patent/CA2406013A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2003533454A (en)	2003-11-11
WO2001087234A3 (en)	2002-02-28
WO2001087234A2 (en)	2001-11-22
CA2406013A1 (en)	2001-11-22
EP1280537A2 (en)	2003-02-05
US20020028190A1 (en)	2002-03-07
US6656459B2 (en)	2003-12-02

Publication	Publication Date	Title
AU2001241474A1 (en)	2001-08-20	Biosensor compositions and methods of use
AU6118001A (en)	2001-11-12	Combination therapeutic compositions and methods of use
AU2001259758A1 (en)	2001-11-26	Interleukin-1 inhibitors in the treatment of diseases
AU2001280597A1 (en)	2002-01-30	Compositions for sustained release of analgesic agents, and methods of making and using the same
AU2001279284A1 (en)	2002-01-14	Rapid-melt semi-solid compositions, methods of making same and methods of using same
EP1576150A3 (en)	2005-09-15	Methods and compositions for increasing the efficacy of biologically-active ingredients
AU7362301A (en)	2002-01-02	Bioadhesive compositions and methods of preparation and use
AU2001280606A1 (en)	2002-01-30	Gel form automatic dishwashing compositions, methods of preparation and use thereof
AU2001281140A1 (en)	2002-02-18	Anti-plasmodium compositions and methods of use
IL161121A0 (en)	2004-08-31	Copolymers for suppression of autoimmune diseases, and methods of use
AU2001266573A1 (en)	2001-11-26	Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof
AU2001250821A1 (en)	2001-09-24	Methods and compositions for the treatment and prevention of erectile dysfunction
AU2003299441A1 (en)	2004-07-14	Nf-hev compositions and methods of use
AU2002350079A1 (en)	2003-06-30	Gel composition and methods of use
AU2001271266A1 (en)	2001-12-03	Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
AU3840802A (en)	2002-06-03	Methods and compositions for the treatment of diseases of the eye
IL155174A0 (en)	2003-10-31	Methods and compositions for the treatment of inflammatory diseases
AU2002241911A1 (en)	2002-07-30	Methods to treat autoimmune and inflammatory conditions
AU2002221273A1 (en)	2002-05-06	Delayed and sustained release formulations and method of use thereof
AU2001259037A1 (en)	2001-12-03	Hydrogenated block copolymer compositions
AU1953701A (en)	2001-06-18	Methods and compositions for treatment of inflammatory disease
AU4515001A (en)	2001-06-18	Compositions and methods for locally treating inflammatory diseases
AU2001271281A1 (en)	2001-12-11	Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU2002355432A1 (en)	2003-02-24	Kavalactone compositions and methods of use
AU2001297794A1 (en)	2002-12-03	Methods and compositions of human proteins and uses thereof.